 |
|
Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women
The Kame Project
Madeline Murguia Rice, PhD;
Amy Borenstein Graves, PhD;
Susan M. McCurry, PhD;
Laura E. Gibbons, PhD;
Jim D. Bowen, MD;
Wayne C. McCormick, MD;
Eric B. Larson, MD, MPH
Arch Intern Med. 2000;160:1641-1649.
Background The relation between estrogen and cognition among postmenopausal women remains controversial. Also uncertain is whether the proposed association varies between women taking unopposed estrogen and those taking estrogen combined with progestin.
Objective To determine whether unopposed estrogen and combined estrogen-progestin use were associated with the rate of cognitive change in a cohort of older, Japanese American, postmenopausal women.
Methods A prospective observational study in a population-based cohort of older Japanese Americans (aged  65 years) living in King County, Washington. Cognitive performance was measured in 837 women at baseline (1992-1994) and 2-year follow-up (1994-1997) examinations using the 100-point Cognitive Abilities Screening Instrument (CASI). Least squares means general linear models were used to estimate the 2-year rate of cognitive change according to categories of postmenopausal estrogen use.
Results Approximately half of this cohort (n=455) had never used estrogen at any time since menopause, 186 were past users, 132 were current unopposed estrogen users, and 64 were current estrogen-progestin users. The majority of current estrogen users were taking conjugated estrogens, and all women receiving combined therapy were taking medroxyprogesterone acetate. After adjusting for age, education, language spoken at the interview, surgical menopause, and baseline CASI score, women who had never used postmenopausal estrogen improved slightly on the CASI scale (mean adjusted change, 0.79; SEM, 0.19). This change was significantly greater for current unopposed estrogen users (mean adjusted change, 1.68; SEM, 0.36; P=.04) and significantly worse for current estrogen-progestin users (mean adjusted change, -0.41; SEM, 0.50; P=.02) compared with never users. The improvement observed in past users (mean adjusted change, 1.12; SEM, 0.29) was intermediate between the changes for never users and current unopposed estrogen users and not significantly greater than that for never users (P=.35).
Conclusions Our findings support a modest beneficial association between current unopposed estrogen use and the rate of cognitive change. We also observed a modest detrimental association between current estrogen-progestin use and the rate of cognitive change. The clinical significance of these modest differences, however, is uncertain. Data from large, long-term randomized trials are required before applying this information to the clinical setting.
From the Departments of Epidemiology (Dr Rice), Medicine (Drs Rice, McCormick, and Larson), Psychosocial and Community Health (Dr McCurry), Environmental Health (Dr Gibbons), and Neurology (Dr Bowen), University of Washington, Seattle; and the Department of Epidemiology and Biostatistics, University of South Florida, Tampa (Dr Graves).
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(11):1708-1709.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Progestin negatively affects hearing in aged women
Guimaraes et al.
Proc. Natl. Acad. Sci. USA 2006;103:14246-14249.
ABSTRACT
| FULL TEXT
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick et al.
J. Clin. Endocrinol. Metab. 2006;91:1802-1810.
ABSTRACT
| FULL TEXT
Surgical Menopause, Estrogen, and Cognitive Function in Women: What Do the Findings Tell Us?
SHERWIN
Ann. N. Y. Acad. Sci. 2005;1052:3-10.
ABSTRACT
| FULL TEXT
Sex, Hormones, and Alzheimer's Disease
Baum
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:736-743.
ABSTRACT
| FULL TEXT
Higher Dietary Intake of Lignans Is Associated with Better Cognitive Performance in Postmenopausal Women
Franco et al.
J. Nutr. 2005;135:1190-1195.
ABSTRACT
| FULL TEXT
Cognition and Dementia
Obstet Gynecol 2004;104:25S-40S.
FULL TEXT
Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial
Kreijkamp-Kaspers et al.
JAMA 2004;292:65-74.
ABSTRACT
| FULL TEXT
Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women: Women's Health Initiative Memory Study
Espeland et al.
JAMA 2004;291:2959-2968.
ABSTRACT
| FULL TEXT
Postmenopausal Hormone Therapy and Its Association With Cognitive Impairment
Mitchell et al.
Arch Intern Med 2003;163:2485-2490.
ABSTRACT
| FULL TEXT
Oestrogen plus progestin doubles the risk of dementia in post-menopausal women
Sherwin and McGill
Evid. Based Ment. Health 2003;6:111-111.
FULL TEXT
Estradiol Increases Pre- and Post-Synaptic Proteins in the CA1 Region of the Hippocampus in Female Rhesus Macaques (Macaca mulatta)
Choi et al.
Endocrinology 2003;144:4734-4738.
ABSTRACT
| FULL TEXT
Effects of Estrogen Plus Progestin on Risk of Dementia
Yoon
JAMA 2003;290:1707-1707.
FULL TEXT
The Need for an Integrated Biopsychosocial Approach to Research on Successful Aging
Inui
ANN INTERN MED 2003;139:391-394.
ABSTRACT
| FULL TEXT
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
Shumaker et al.
JAMA 2003;289:2651-2662.
ABSTRACT
| FULL TEXT
Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
Rapp et al.
JAMA 2003;289:2663-2672.
ABSTRACT
| FULL TEXT
Alcohol, Aging, and Cognitive Performance:: A Cross-Cultural Comparison
Bond et al.
J Aging Health 2003;15:371-390.
ABSTRACT
Estrogen and Cognitive Functioning in Women
Sherwin
Endocr. Rev. 2003;24:133-151.
ABSTRACT
| FULL TEXT
Cognitive Decline Among Female Estrogen Users in Nursing Homes
Ott et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:M594-598.
ABSTRACT
| FULL TEXT
Impact of Progestins on Estrogen-Induced Neuroprotection: Synergy by Progesterone and 19-Norprogesterone and Antagonism by Medroxyprogesterone Acetate
Nilsen and Brinton
Endocrinology 2002;143:205-212.
ABSTRACT
| FULL TEXT
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc et al.
JAMA 2001;285:1489-1499.
ABSTRACT
| FULL TEXT
|
